Publications by authors named "Daniel Reschke"

Claim this Profile
C
Current treatment landscape of pancreatic cancer patients in a network of office-based oncologists in Germany.
Susanna Hegewisch-Becker, Karsten Kratz-Albers, Jan Wierecky, Steffen Gerhardt, Daniel Reschke

Future Oncol· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pheochromocytoma Crisis in the Emergency Department.
Stephanie R Bartikoski, Daniel J Reschke

Cureus· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of Central Venous Access with Accelerated Seldinger Technique Versus Modified Seldinger Technique.
Lane Thaut, Wells Weymouth, Branden Hunsaker, Daniel Reschke

J Emerg Med· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An unusual cause of shoulder pain and weakness.
Daniel Reschke, Richard Dagrosa, David T Matteson

Am J Emerg Med· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A brief instrument to measure health-related quality-of-life in patients with bone metastasis: validation of the German version of Bone Metastases Quality-of-Life-10 (BOMET-QoL-10).
Norbert Marschner, Jochen Wilke, Daniel Reschke, Florian Kaiser, Claudia Schmoor

J Med Econ· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chest pain in a young female.
Paul S Basel, Daniel Reschke, Michael D April

Am J Emerg Med· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low-dose fludarabine with or without darbepoetin alfa in patients with chronic lymphocytic leukemia and comorbidity: primary results of the CLL9 trial of the German CLL Study Group.
Valentin Goede, Raymonde Busch, Jasmin Bahlo, Viktoria Chataline, Stephan Kremers, Daniel Reschke

Leuk Lymphoma· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bortezomib-containing regimens are effective in multiple myeloma--results of a non-interventional phase IV study.
Wolfgang Knauf, Christoph Tapprich, Rudolf Schlag, Stefan Schütz, Burkhard Alkemper, Daniel Reschke

Oncol Res Treat· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In response to "Scope of shared decision making in patients with psychologic complaints".
Daniel J Reschke, Zachary H Seeskin, Elizabeth A Hahn, Peter S Pang

Am J Emerg Med· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient preferences regarding medical decision making in the emergency care setting: a pilot-study.
Daniel J Reschke, Zachary H Seeskin, Elizabeth A Hahn, Peter S Pang

Am J Emerg Med· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bendamustine plus mitoxantrone for relapsed/refractory chronic lymphocytic leukaemia (CLL): results of a multicentre phase II study of the German CLL Study Group (GCLLSG).
Hubert Köppler, Harald Fuss, Hans J Hurtz, Owe Knigge, Christoph Losem, Daniel Reschke

Br J Haematol· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Late infectious complications after high-dose therapy and autologous blood stem cell transplantation].
Bernd Metzner, Ricarda Grüneisl, Wolfgang Gebauer, Daniel Reschke, Ekkehard Ost

Med Klin (Munich)· November 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis